Menu Search
Equities

TianYu Bio-Technology Co Ltd

603717:SHH

TianYu Bio-Technology Co Ltd

Actions
IndustrialsConstruction and Materials
  • Price (CNY)4.92
  • Today's Change-0.06 / -1.20%
  • Shares traded1.94m
  • 1 Year change-28.28%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year TianYu Bio-Technology Co Ltd's revenues fell -29.05% from 944.91m to 670.45m. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from a loss of 279.41m to a larger loss of 494.43m.
Gross margin-20.47%
Net profit margin-67.63%
Operating margin-69.66%
Return on assets-13.01%
Return on equity-46.68%
Return on investment-21.49%
More ▼

Cash flow in CNYView more

In 2023, cash reserves at TianYu Bio-Technology Co Ltd fell by 146.51m. Cash Flow from Financing totalled 131.66m or 19.64% of revenues. In addition the company used 175.93m for operations while cash used for investing totalled 102.24m.
Cash flow per share--
Price/Cash flow per share--
Book value per share2.25
Tangible book value per share2.13
More ▼

Balance sheet in CNYView more

TianYu Bio-Technology Co Ltd has a Debt to Total Capital ratio of 61.54%, a lower figure than the previous year's 99.15%.
Current ratio1.30
Quick ratio1.11
Total debt/total equity2.13
Total debt/total capital0.6154
More ▼

Growth rates in CNY

Year on year, growth in earnings per share excluding extraordinary items dropped -47.47%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		60.96
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.